Non‐ Aspergillus invasive mould infections in patients treated with ibrutinib
Author:
Affiliation:
1. Department of Infectious Diseases Infection Control, and Employee Health MD Anderson Cancer Center University of Texas Houston Houston TX USA
2. Division of Pharmacy MD Anderson Cancer Center University of Texas Houston Houston TX USA
Funder
Astellas Pharma US
Publisher
Wiley
Subject
Infectious Diseases,Dermatology,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/myc.13120
Reference48 articles.
1. Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
2. Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
3. Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study
4. Long-term follow-up of MCL patients treated with single-agent ibrutinib: updated safety and efficacy results
5. Targeting Bruton tyrosine kinase with ibrutinib in relapsed/refractory marginal zone lymphoma
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Clinical Mycology Today: Emerging Challenges and Opportunities;Open Forum Infectious Diseases;2024-06-27
2. The Impact of Dimitrios P. Kontoyiannis on Mucormycosis Research;Journal of Fungi;2024-05-27
3. Prevention and management of infectious complications in patients with chronic lymphocytic leukemia (CLL) treated with BTK and BCL-2 inhibitors, focus on current guidelines;Blood Reviews;2024-05
4. How I manage acute respiratory failure in patients with hematological malignancies;Blood;2024-03-14
5. Risk of Invasive Fungal Infections in Patients With Chronic Lymphocytic Leukemia Treated With Bruton Tyrosine Kinase Inhibitors: A Case-Control Propensity Score–Matched Analysis;Open Forum Infectious Diseases;2024-02-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3